A detailed history of Callan Family Office, LLC transactions in Entegris Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 5,123 shares of ENTG stock, worth $401,028. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,123
Previous 8,557 40.13%
Holding current value
$401,028
Previous $690 Million 31.36%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$72.03 - $95.97 $247,351 - $329,560
-3,434 Reduced 40.13%
5,123 $474 Million
Q2 2025

Jul 24, 2025

BUY
$62.92 - $86.2 $366,068 - $501,511
5,818 Added 212.41%
8,557 $690 Million
Q1 2025

May 12, 2025

SELL
$87.48 - $109.53 $32,192 - $40,307
-368 Reduced 11.84%
2,739 $240 Million
Q4 2024

Feb 06, 2025

BUY
$97.67 - $112.92 $303,460 - $350,842
3,107 New
3,107 $308 Million

Others Institutions Holding ENTG

About ENTEGRIS INC


  • Ticker ENTG
  • Exchange NASDAQ
  • Sector Technology
  • Industry Semiconductor Equipment & Materials
  • Shares Outstandng 148,964,000
  • Market Cap $11.7B
  • Description
  • Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Specialty Chemicals and Engineered Materials (SCEM); Microcontamination Control (MC...
More about ENTG
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.